These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2632215)

  • 41. Ecophylaxis: preventive treatment with gentamicin of rabbit lincomycin-associated diarrhea.
    Fesce A; Ceccarelli A; Fesce E; Balsari A
    Folia Vet Lat; 1977; 7(3):225-42. PubMed ID: 350739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Macrolides and lincomycins].
    Goto Y; Nasu M
    Nihon Rinsho; 1990 Oct; 48(10):2189-95. PubMed ID: 2280463
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship between the chemotherapeutic effectiveness of ciclacillin and ampicillin and the time of their administration in experimental infections.
    Arend P; Sous H; Poszich G; Mŭckter H
    Arzneimittelforschung; 1975 Sep; 25(9):1382-5. PubMed ID: 1103895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Watanabe T; Yamamoto M; Hirai Y; Ajito K
    J Antibiot (Tokyo); 2016 Jun; 69(6):428-39. PubMed ID: 26669751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin B.
    Kumar V; Jones GS; Blacksberg I; Remers WA; Misiek M; Pursiano TA
    J Med Chem; 1980 Jan; 23(1):42-9. PubMed ID: 6244410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin.
    Ueo K; Fukuoka Y; Hayashi T; Yasuda T; Taki H; Tai M; Watanabe Y; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1977 Oct; 12(4):455-60. PubMed ID: 921239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
    Crowe CC; Sanders WE
    Antimicrob Agents Chemother; 1974 Mar; 5(3):272-5. PubMed ID: 4840436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sensitivity of pathogens of post-ventilation pneumonia in newborns to antibacterial drugs].
    Abrosimova NA; Kushnareva MV; Nisan LG
    Antibiot Khimioter; 1994 Jan; 39(1):38-41. PubMed ID: 8060194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin.
    Venturini AP; Marchi E
    Chemioterapia; 1986 Aug; 5(4):257-62. PubMed ID: 3533285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on the disc method for the determination of bacterial sensitivity to ribostamycin (author's transl)].
    Kanazawa Y; Kuramata T
    Jpn J Antibiot; 1976 Aug; 29(8):725-30. PubMed ID: 957521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of synergism of ampicillin and gentamicin in experimental listeriosis.
    Hof H; Gückel H
    Infection; 1987; 15(1):40-1. PubMed ID: 3570481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploration of Antibiotic Activity of Aminoglycosides, in Particular Ribostamycin Alone and in Combination With Ethylenediaminetetraacetic Acid Against Pathogenic Bacteria.
    Kong J; Wu ZX; Wei L; Chen ZS; Yoganathan S
    Front Microbiol; 2020; 11():1718. PubMed ID: 32849365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asparenomycins A, B and C, new carbapenem antibiotics. IV. Antibacterial activity.
    Kimura Y; Motokawa K; Nagata H; Kameda Y; Matsuura S; Mayama M; Yoshida T
    J Antibiot (Tokyo); 1982 Jan; 35(1):32-8. PubMed ID: 7068514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Butirosin compared with gentamicin in vitro and in vivo.
    Heifetz CL; Chodubski JA; Pearson IA; Silverman CA; Fisher MW
    Antimicrob Agents Chemother; 1974 Aug; 6(2):124-35. PubMed ID: 15828182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of gentamicin to prevent intestinal side effects of lincomycin therapy.
    Fesce E; Tittobello A; Cambielli M; Balsari A; Guslandi M; Evangelista A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):495-502. PubMed ID: 730415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 1. Newly generated antibacterial activities against Gram-positive bacteria with erm gene by C-7 modification.
    Wakiyama Y; Kumura K; Umemura E; Ueda K; Masaki S; Kumura M; Fushimi H; Ajito K
    J Antibiot (Tokyo); 2016 May; 69(5):368-80. PubMed ID: 26669755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. "Once, all the world was anaerobic".
    Madeiros AA
    N Engl J Med; 1972 Nov; 287(20):1041-2. PubMed ID: 4650970
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima).
    Kuck NA
    Antimicrob Agents Chemother; 1976 Mar; 9(3):493-7. PubMed ID: 176936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The pharmacokinetics of lincomycin when used as a component of a drug combination with ultrahighly dispersed hydroxyapatite].
    Zuev VP; Pankratov AS; Sergeev PV; Bolotova EN; Semeĭkin AV
    Stomatologiia (Mosk); 1998; 77(6):19-22. PubMed ID: 10067409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic antibacterial effect between silibinin and antibiotics in oral bacteria.
    Lee YS; Jang KA; Cha JD
    J Biomed Biotechnol; 2012; 2012():618081. PubMed ID: 21941436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.